Rhonda Farnum - Dec 1, 2021 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: SVP, Comm & Medical Affairs
Signature: Brett A. Grimaud, Attorney-in-Fact
Stock symbol: TBPH
Transactions as of: Dec 1, 2021
Transactions value $: $0
Form type: 3
Date filed: 12/10/2021, 05:34 PM
Next filing: Dec 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TBPH	Ordinary Shares						320K	Dec 1, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TBPH	Share Option (Right to Buy)							Dec 1, 2021	Ordinary Shares	150K	$25.64	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested and became exercisable on August 1, 2019, then 1/48th of the shares subject to the option vest became exercisable each month thereafter. The Option shall be fully vested and exercisable on August 1, 2022 provided optionee has remained in continuous service through such date.